Lumipulse® G KL-6 (Krebs von den Lungen)
Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of sialylated carbohydrate antigen, KL-6 in serum or plasma.
The assay utilises proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
You will find more resources about ILDs and the KL-6 biomarker in our dedicated microsite at www.fujirebio.com/kl-6 (opens in a new window).
Product number 234594
Product number 234600
Click here to navigate
- Contact sales for information
- Details
- Conditions of sale
- Documentation
- Insights
- FAQ
- Related products
- Product inquiry
-
Details
See the LUMIPULSE G1200 working in this video:
-
Conditions of sale
To read the end user conditions of sale for this product please visit our Resource center.
-
Documentation
Browse regulatory documents for this product
Create a (free!) eServices account and start browsing all regulatory documentation right away.
Other documents
FileKL-6 Whitepaper (pdf, 378.50 kb)Extra informationGuidance document on the value of measuring KL-6 in the field of lung diseases.FileKL-6 Biomarker Information - Physician Leaflet (pdf, 3.71 mb)FileLumipulse G Lung Disease Management brochure (pdf, 151.32 kb)Get access to this section and more
Create a free eServices account now and instantly access multiple digital resources:
- Regulatory product documentation
- Selected scientific posters
- Product leaflets
- How-to videos and more…
-
Insights
Jan 6, 2022Oct 15, 2020 -
FAQ
How does the coronavirus disease Covid-19 impact Fujirebio's operations?Please see the following statement on the impact of coronavirus disease Covid-19 on the operations of Fujirebio Europe (updated January 19, 2021).
-
Related products
-
Product inquiry